1. 5PSQ-089 Cytokine release syndrome reaction: the clinical pharmacist in the chimeric antigen receptor T cell therapy team. (24th March 2020) Authors: Del Vecchio, M; Minniti, E; Lauria Pantano, C; Lo Cricchio, G; Ruffino, E; Handschin, G; Ladisa, V Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5PSQ-097 Toxicity associated with gene polymorphisms in patients with colorectal cancer, treated with fluoropyrimidines and analogues, irinotecan and platinum coordination complexes. (2nd March 2018) Authors: Cricchio, G Lo; Saibene, G; Ruffino, E; Laganà, G; Costanza, C Della; Pietrantonio, F; Falvella, S; Nichetti, F; Celotti, FM; Ladisa, V Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5PSQ-101 Oncolytic viruses risk and control assessment: talimogene laherparepvec experience. (2nd March 2018) Authors: Costanza, C Della; Saibene, G; Laganà, G; Ruffino, E; Antonacci, G; Langella, R; Mauro, C Di; Galassi, M; Re, B; Ladisa, V Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PS-033 Ifosfamide induced encephalopathy: prophylaxis and therapy with methylene blue. (25th February 2017) Authors: Gambitta, L; Togliardi, E; Cusmai, R; Costanza, C Della; Nurro, S; Ruffino, E; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗